Angus Dalgleish

Dalgleish is a member of the UK Independence Party and stood as a candidate in Sutton & Cheam, during the 2015 United Kingdom general election finishing fourth with 10.7% of the vote. Unlike many of his colleagues in the scientific community, he campaigned for Leave.EU and appeared on the BBC Radio 4 Today programme presenting the case for Brexit.

Dalgleish was elected a Fellow of the Academy of Medical Sciences in 2001 and is also a Fellow of the Royal College of Physicians the Royal College of Pathologists and a Fellow of the Royal Australasian College of Physicians. His citation on election to FMedSci reads:

In 1997, he founded Onyvax Ltd., a privately funded biotechnology company developing cancer vaccines, where he held the position as Research Director. The company dissolved in 2013 after filing for insolvency in 2008. He is also a member of the medical board in Bionor Pharma.

After completion of his training, Dalgleish returned to work in the UK in 1984 at the Institute of Cancer Research, where he helped identify CD4 as the major cellular receptor for HIV. In 1986, he was appointed to a consulting position at Northwick Park Hospital, in 1991 he was made Foundation Professor of Oncology at St George's, University of London, and in 1994 he was appointed Visiting Professor at the Institute of Cancer Research in London.

Angus George Dalgleish (born May 1950) FRCP FRCPath FMedSci is a professor of oncology at St George's, University of London, best known for his contributions to HIV/AIDS research. Dalgleish stood in 2015 for Parliament as a UKIP candidate.

Angus George Dalgleish was born in May 1950 in Harrow, London. Initially educated at the Harrow County School for Boys, Dalgleish received a Bachelor of Medicine, Bachelor of Surgery degree from University College London with an intercalated bachelor's degree in Anatomy.